The E3 ubiquitin ligase SCF (FBXW10)-mediated LATS2 degradation regulates angiogenesis and liver metastasis in colorectal cancer
The International Journal of Biochemistry & Cell Biology · 2023
DOI: 10.1016/j.biocel.2023.106408 ↗Kurz gefasst
Fachartikel in der Zeitschrift The International Journal of Biochemistry & Cell Biology, 2023. Verfasst von Zheng-Yun Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200233, China. Hauptthemen laut MEDLINE: Liver Neoplasms, Colorectal Neoplasms, F-Box Proteins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shanghai Jiao Tong University, Natural Science Foundation of Shanghai.
Abstract (Originalsprache)
F-box and WD repeat domain containing 10 (FBXW10) is a member of the FBXW subgroup that contains the WD40 domain. FBXW10 has been rarely reported in colorectal cancer (CRC) and its mechanism is unclear. To investigate the role of FBXW10 in CRC, we conducted in vitro and in vivo experiments. Through the database and our clinical samples, we found that FBXW10 expression was up-regulated in CRC, and it was positively correlated with CD31 expression. CRC patients with high FBXW10 expression levels had a poor prognosis. Overexpression of FBXW10 up-regulated cell proliferation, migration and vascular formation, while knockdown of FBXW10 had the opposite effects. Studies on the mechanism of FBXW10 in CRC showed that FBXW10 could ubiquitinate large tumor suppressor kinase 2 (LATS2) and promote its degradation with the Fbox region of FBXW10 played an essential role in this process. In vivo studies demonstrated that knockout of FBXW10 inhibited tumor proliferation and reduced liver metastasis. In conclusion, our study proved that FBXW10 was significantly overexpressed in CRC and was involved in the pathogenesis of CRC by affecting angiogenesis and liver metastasis. Mechanistically, FBXW10 degraded LATS2 through ubiquitination. Therefore, FBXW10-LATS2 can be used as a therapeutic target for CRC in subsequent studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200233, China.
- Department of Emergency Medicine, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200233, China.
- Department of Surgery, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200233, China. Electronic address: guanjiao0727@163.com.
- Department of Surgery, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200233, China. Electronic address: surgeon_zhou@163.com.
Förderung
- National Natural Science Foundation of China
- Shanghai Jiao Tong University
- Natural Science Foundation of Shanghai
Zitieren
APA
Zhang, Z. Y., Sun, J. H., Liang, M. J., Wang, X. P., Guan, J., & Zhou, Z. Q. (2023). The E3 ubiquitin ligase SCF (FBXW10)-mediated LATS2 degradation regulates angiogenesis and liver metastasis in colorectal cancer. The International Journal of Biochemistry & Cell Biology. https://doi.org/10.1016/j.biocel.2023.106408
Vancouver
Zhang ZY, Sun JH, Liang MJ, Wang XP, Guan J, Zhou ZQ. The E3 ubiquitin ligase SCF (FBXW10)-mediated LATS2 degradation regulates angiogenesis and liver metastasis in colorectal cancer. The International Journal of Biochemistry & Cell Biology. 2023. doi:10.1016/j.biocel.2023.106408
BibTeX
@article{Zhang2023,
author = {Zhang, Zheng-Yun and Sun, Jian-Hua and Liang, Ming-Jun and Wang, Xin-Ping and Guan, Jiao and Zhou, Zun-Qiang},
title = {The E3 ubiquitin ligase SCF (FBXW10)-mediated LATS2 degradation regulates angiogenesis and liver metastasis in colorectal cancer},
journal = {The International Journal of Biochemistry & Cell Biology},
year = {2023},
doi = {10.1016/j.biocel.2023.106408}
}
EUVIMED